NeuroMetrix to Present at Canaccord Genuity Medical Technology & Diagnostics Forum WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 7, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the treatment and management of the neurological complications of diabetes,
NeuroMetrix to Present at Canaccord Genuity Medical Technology & Diagnostics Forum WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 27, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes,
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Canaccord Genuity Medical Technology and Diagnostics Forum at the Westin Grand Central , New York, NY on November
NeuroMetrix to Present at Canaccord Genuity Musculoskeletal Conference WALTHAM, Mass., Feb 09, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a health care company transforming patient care through neurotechnology, today announced that Shai N.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO) announced today that Shai N. Gozani, M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the First Look Equities Summit at the City Club of Buckhead in Atlanta, GA on April 26, 2016 . Dr.
WOBURN, Mass. , Jan. 05, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the H.C. Wainwright BioConnect Conference to be held virtually on January 10-13, 2022 . Dr.
Presentation Shifted to 10:00 am on September 6, 2018 WALTHAM, Mass. , Aug. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix , Inc. (Nasdaq:NURO) reported that the time previously announced for its presentation at the H.C.Wainwright 20th Annual Global Investment Conference has been shifted to 10:00 am
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NURO ), a health-care company that develops wearable medical technology and point-of-care tests, reported that Shai N. Gozani M.D ., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Rodman & Renshaw 17 th Annual Global
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 3, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on management of chronic pain and peripheral neuropathies, today announced that Shai N.
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass., Sep 07, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), a science-based health care company improving patient care through neurotechnology, today announced that Shai N.
